Semaglutide adverse effects: what the evidence says and how to weigh them up

The decision most people are actually facing

If you are researching semaglutide's adverse effects right now, you are probably weighing a real question: is the benefit worth the discomfort? That is an honest and sensible thing to ask, and it deserves a straight answer rather than a list of bullet points lifted from a package leaflet.

The short version is this: for most people, the adverse effects of Wegovy are front-loaded. Nausea tends to be worst in the first few days after each new dose, then retreats. Diarrhoea or constipation can alternate in some people. Fatigue and headache appear in the early weeks for a smaller number. These effects are real, sometimes genuinely unpleasant, and they are also the reason treatment starts at the lowest dose and increases slowly, the titration schedule is designed precisely to give the body time to adapt.

Understanding the full picture of how semaglutide affects the body helps put individual symptoms in context. The NHS's patient-level guidance on semaglutide lists all known adverse effects by frequency, and reading it alongside a prescriber's assessment is the right combination.

Adverse effects of Wegovy that need prompt medical attention

Most of what people experience with semaglutide is uncomfortable rather than dangerous. A handful of effects, though, deserve immediate action rather than waiting to see.

Pancreatitis is the most important one to know about. In January 2026, the MHRA published a Drug Safety Update confirming acute pancreatitis as a known, infrequent but potentially serious adverse effect across the GLP-1 medicine class. The sign to act on is severe abdominal pain (particularly if it radiates into your back and persists rather than coming and going) with or without vomiting. That symptom requires same-day medical assessment, not a pause to check whether it might be indigestion. You can read the MHRA's full communications on GLP-1 safety via the Yellow Card reporting site.

Gallbladder problems are another class-wide effect worth knowing: gallstones and inflammation of the gallbladder have been reported in people taking GLP-1 medicines. Severe pain in the upper right abdomen, especially after eating, should be assessed promptly.

Severe dehydration from prolonged vomiting or diarrhoea can cause kidney strain. If you cannot keep fluids down for more than 24 hours, or you notice significantly reduced urination, contact a clinician. A broader look at the less common adverse effects of semaglutide covers these scenarios in more detail.

Allergic reactions are rare but possible: facial swelling, difficulty breathing, or a severe rash that develops quickly after injection requires emergency care.

Adverse effects that are commonly manageable (and how

It would be misleading to frame the GI side effects as trivial) some people find the nausea in the first few weeks genuinely disruptive. It would also be misleading to suggest they are inevitable or permanent. In the STEP 1 clinical trial, published in the New England Journal of Medicine, the large majority of GI events were mild to moderate in severity and resolved without stopping treatment.

Several practical things make a difference. Eating smaller portions at each meal and avoiding rich, fatty foods tends to reduce nausea. Staying well hydrated helps with constipation. Taking the injection at a consistent time each week (and on a day when a difficult next morning is manageable) gives people some control over the timing of any peak effects.

Injection-site reactions (redness, mild swelling, itching) can occur but rarely require action beyond rotating injection sites: the abdomen, thigh, and upper arm are all suitable, and the same spot twice in a row is worth avoiding.

Questions about whether a specific adverse effect warrants a dose pause or adjustment should go to your prescriber rather than being resolved unilaterally. The longer-term picture after semaglutide treatment is a separate question from the acute side-effect profile, and one our clinical team fields regularly.

One consideration people often raise late: other medicines you take

Semaglutide slows gastric emptying, which can alter the rate at which other oral medicines are absorbed. This is worth raising with whoever reviews your full medication list before you start. For most common medicines the clinical significance is small, but it is not zero, and a prescriber should have the full picture, including any supplements or over-the-counter products taken regularly.

Blood pressure is a related consideration: some people ask whether semaglutide affects blood pressure readings, particularly in the context of existing antihypertensive medicines. Weight loss itself tends to lower blood pressure over time, which occasionally means existing medication doses need revisiting.

If you are thinking seriously about starting treatment and want a prescriber to look at your individual adverse-effect risk (including your current medicines, health history, and the cost of private treatment) the right next step is a clinical consultation. You can speak to our prescribers through a free consultation; a GPhC-registered independent prescriber at our UK pharmacy reviews every case personally before any prescription is issued.